Monthly information on share capital and company voting rights

Rhea-AI Summary

Cellectis (CLLS) has released its monthly share capital and voting rights report as required by Article 223-16 of the French financial markets authority's General Regulation. The company's shares are listed on Euronext Growth under ISIN code FR0010425595.

News Market Reaction

+2.87%

1 alert

+2.87% News Effect

On the day this news was published, CLLS gained 2.87%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, March 06, 2025 (GLOBE NEWSWIRE) --

Listing market: Euronext Growth

ISIN code: FR0010425595

Date	Total number of shares in the capital	Total number of voting rights
02/28/2025	100,093,873	88,849,752

For further information on Cellectis, please contact:     

Media contacts:       

Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com

Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93

Investor Relations contact:       

Arthur Stril, Chief Financial Officer & Chief Business Officer, investors@cellectis.com       

Attachment

• Voting_Rights_PR_February_2025_EN

FAQ

What regulatory requirement is Cellectis (CLLS) fulfilling with this announcement?

Cellectis is fulfilling Article 223-16 of French financial markets authority's General Regulation requiring monthly disclosure of share capital and voting rights.

Where are Cellectis (CLLS) shares listed for trading?

Cellectis shares are listed on Euronext Growth market with ISIN code FR0010425595.

When was this share capital and voting rights report released by Cellectis (CLLS)?

The report was released on March 06, 2025.

Who are the key contacts for Cellectis (CLLS) investor relations?

Arthur Stril serves as Chief Financial Officer & Chief Business Officer, handling investor relations inquiries.